SCHEMBL4669545

SCHEMBL4669545

Clc1ncccc1Br.Nc1ccc(Oc2ncccc2Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
APAF1 O14727 1/20 0.47
PDE10A Q9Y233 6/20 0.43
RAB9A P51151 1/20 0.43
MAOA P21397 2/20 0.40
MAPT P10636 2/20 0.40
MAOB P27338 1/20 0.40
DRD1 P21728 1/20 0.37
ALDH1A1 P00352 3/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MITF O75030 1/20 0.35
GAA P10253 1/20 0.35
GFER P55789 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NLRP1 Q9C000 1/20 0.35
NOD2 Q9HC29 1/20 0.35
GCK P35557 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL580112 0.91 MEN1 (0.56) MEN1KMT2AAPAF1PDE10ARAB9A
SCHEMBL4667183 0.82 KDM4E (0.42) MEN1KMT2AAPAF1PDE10ARAB9A
SCHEMBL2488534 0.81 RAB9A (0.56) MEN1KMT2APDE10ARAB9AMAPT
SCHEMBL15044336 0.78 MEN1 (0.56) MEN1KMT2AAPAF1PDE10ARAB9A
SCHEMBL1304578 0.77 MAOA (0.50) MEN1KMT2AAPAF1RAB9AMAOA
SCHEMBL20406250 0.77 PDE10A (0.45) MEN1KMT2APDE10ARAB9ADRD1
SCHEMBL4008329 0.76 PDE10A (0.51) MEN1KMT2APDE10AMAPTDRD1
SCHEMBL122934 0.75
SCHEMBL29622282 0.75
SCHEMBL20406610 0.74 PDE10A (0.51) MEN1KMT2APDE10ARAB9ADRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984353-A1 AURORA KINASE MODULATORS AND METHOD OF USE Amgen, Inc (US) 2008-10-29 EP disclosed
WO-2007087276-A1 AURORA KINASE MODULATORS AND METHOD OF USE AMGEN INC. (US) 2007-08-02 WO disclosed